GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a significant focus in healthcare investigation, largely due to its remarkable impact on managing diseases such as type 2 diabetes and obesity. Recent studies have shown that beyond glucose management, GLP-1 medications offer potential for heart function and even cog